CJC-1295 + Ipamorelin: A Research Overview
A two-peptide research blend pairing a GHRH analog with a selective secretagogue. An overview of the components, research context, and how the blend is characterized.
CJC-1295 + Ipamorelin is a two-peptide research blend that pairs a growth-hormone-releasing hormone (GHRH) analog with a selective secretagogue. This overview explains the components for research context.
The two components
CJC-1295 (no DAC / Mod GRF 1-29)
- A modified 29-residue GHRH analog
- CAS number: 863288-34-0
Ipamorelin
- A 5-residue selective growth-hormone secretagogue
- CAS number: 170851-70-4
The two are combined because they act on different points of the growth-hormone axis, which is why the pair is a common subject in secretagogue research.
Research context
This blend is studied in in-vitro and laboratory research into the growth-hormone axis and secretagogue signaling. It is supplied strictly as a research compound.
The above is molecular and research-context information only — it is not a description of human, clinical, athletic, or therapeutic use, and no such use is implied.
How it's characterized
Because it's a blend, a good Certificate of Analysis identifies each component and reports HPLC purity. New to COAs? Start with how to read a Certificate of Analysis and HPLC purity explained.
Handling
Supplied lyophilized — store the sealed powder cold, dark, and dry, and follow standard reconstitution practice; see lyophilized peptide storage & handling.
In the catalog
View the current batch, purity, and COA for our CJC-1295 + Ipamorelin blend.
For laboratory research use only. Not for human or veterinary use.
For Research Use Only
Hexa Research cannot answer dosage, protocol, human-use, veterinary-use, or medical questions. All products are sold strictly for laboratory and in-vitro research use by qualified researchers and institutions.